Systemic Sclerosis Living

Following the Supreme Court’s decision in June overturning Roe v. Wade, communication regarding effective and safe birth control in certain patients, including those with lupus and other rheumatic disease, has become immensely important.

Diastolic dysfunction is an independent risk factor for increased mortality risk among patients with systemic sclerosis, according to a study published in Arthritis & Rheumatology.

A number of new therapies, including immunosuppressive drugs and drug combinations, have shown efficacy in mitigating scleroderma-associated interstitial lung disease, according to a speaker at the ACR State-of-the-Art Clinical Symposium.